Role of Spleen educated monocytes in mediating ischemia-reperfusion injury following lung transplant
脾脏单核细胞在介导肺移植后缺血再灌注损伤中的作用
基本信息
- 批准号:10132385
- 负责人:
- 金额:$ 59.15万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-04-01 至 2023-03-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAllograftingAlveolarAlveolar MacrophagesAtlasesBiopsyBlood VesselsBone MarrowCCL2 geneCX3CL1 geneCaringCellsChronicClinicalDataDevelopmentDiseaseDonor personEndotheliumExperimental DesignsExtravasationFractalkineFunctional disorderGenesGeneticGenetic studyHerpes zoster diseaseHourHumanHypoxemiaImageImmuneInflammasomeInjuryInterleukin-1 betaInterventionLifeLungLung TransplantationLung diseasesMediatingMembraneMolecularMusMutateNeutrophil InfiltrationOrganOutcomePaperPathologicPatient-Focused OutcomesPatientsPharmacologyProductionProteinsPublishingPulmonary InflammationReceptor ActivationReperfusion InjuryReperfusion TherapyReportingRespiratory FailureRisk FactorsRoleSavingsSignal PathwaySignal TransductionSpleenSplenic Red PulpStructure of parenchyma of lungSyndromeSystemTLR2 geneTestingTight JunctionsTimeToll-like receptorsTransforming Growth Factor betaTransgenic OrganismsTranslationsTransplantationVariantallograft rejectionclinical applicationclinical practiceclinically relevantexperimental studygenetic approachimprovedinterstitiallung injurymacrophagemonocytemortalitymouse modelneutrophilnovel therapeuticspathogenpost-transplantreconstitutionrecruitresponsesevere injuryspleen transplantationtwo-photon
项目摘要
PROJECT SUMMARY Primary graft dysfunction (PGD) after lung transplantation, resulting from ischemia
reperfusion injury (IRI), is the predominant cause of poor lung transplant outcomes. Pathologically, PGD is
characterized by neutrophil extravasation into the alveolar space. In murine models of lung transplantation,
NETosis of extravasated neutrophils induces irreversible allograft injury. Non-selective depletion of neutrophils
can ameliorate PGD, but is not clinically feasible given their importance in pathogen clearance. Accordingly,
we have focused on understanding the specific mechanisms that drive neutrophil extravasation into the
allograft leading to PGD after lung transplantation. We discovered that after lung transplantation, Ly6ClowCCR2-
non-classical monocytes (NCM), retained in the donor lung, and Ly6ChighCCR2+ classical monocytes (CM),
recruited to the allograft, are both necessary for the extravasation of neutrophils into the interstitial space and
the resulting lung injury. Both NCM and CM produce IL-1β in response to IRI, with differing consequences. We
present preliminary data suggesting that IL-1β produced by NCM activates donor alveolar macrophages (AM),
inducing their secretion of monocyte chemoattractant protein 1 (MCP-1) which results in recruitment of CM.
Our data also demonstrates that CM recruited to the allograft further produce IL-1β in response to signaling
through toll-like receptors, which permeabilizes the endothelium by downregulating the tight junction protein,
Zona Occludens 2 (ZO-2), to promote neutrophil extravasation. Using a genetic lineage tracing system and
heterochronic spleen transplants we reported that CMs originating in the bone marrow receive signals from the
spleen necessary for their function in mediating neutrophil extravasation after transplantation revealing the
spleen as an active immune organ in this response. We present preliminary data to support our hypothesis that
after lung transplantation, IL-1β released by donor NCM induces the secretion of MCP-1 from donor alveolar
macrophages, which is necessary for the recruitment of recipient CM primed by splenic red pulp macrophages.
This results in sustained IL-β signaling in the allograft that promotes neutrophil extravasation and graft injury.
We will test this hypothesis in two aims. Aim 1. To determine whether donor NCM and alveolar
macrophage-dependent MCP-1 secretion recruits host splenic CM to mediate neutrophil extravasation
after lung transplantation. Aim 2. To determine whether splenic endothelial fractalkine retains CM
recruited by TGF-β released from red pulp macrophages to prime the NLRP3 inflammasome. We use
causal genetic strategies in mouse models identify disease mechanisms and tie these experiments to
applicable therapies that can be tested in humans. In addition, we have taken care to pair our results with
unbiased analyses of human lung tissue obtained from biopsies of the donor lung before and at several times
after reperfusion during lung transplantation to create a molecular atlas of human ischemia reperfusion injury.
These studies will facilitate the rapid translation of our findings to clinical practice.
肺移植术后原发性移植物功能障碍(PGD),由缺血引起
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ankit Bharat其他文献
Ankit Bharat的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ankit Bharat', 18)}}的其他基金
Role of spleen educated monocytes in mediating ischemia-reperfusion injury followinglung transplant surgery
脾脏单核细胞在介导肺移植术后缺血再灌注损伤中的作用
- 批准号:
10661445 - 财政年份:2019
- 资助金额:
$ 59.15万 - 项目类别:
Role of Spleen educated monocytes in mediating ischemia-reperfusion injury following lung transplant
脾脏单核细胞在介导肺移植后缺血再灌注损伤中的作用
- 批准号:
9900589 - 财政年份:2019
- 资助金额:
$ 59.15万 - 项目类别:
Donor nonclassical monocytes initiate lung injury following transplantation
供体非经典单核细胞在移植后引发肺损伤
- 批准号:
10318938 - 财政年份:2019
- 资助金额:
$ 59.15万 - 项目类别:
Pathogenesis of lung injury mediated by lung-restricted antibodies
肺限制性抗体介导的肺损伤的发病机制
- 批准号:
10372131 - 财政年份:2019
- 资助金额:
$ 59.15万 - 项目类别:
Role of Spleen educated monocytes in mediating ischemia-reperfusion injury following lung transplant
脾脏单核细胞在介导肺移植后缺血再灌注损伤中的作用
- 批准号:
9765907 - 财政年份:2019
- 资助金额:
$ 59.15万 - 项目类别:
Pathogenesis of lung injury mediated by lung-restricted antibodies
肺限制性抗体介导的肺损伤的发病机制
- 批准号:
10673371 - 财政年份:2019
- 资助金额:
$ 59.15万 - 项目类别:
Role of Spleen educated monocytes in mediating ischemia-reperfusion injury following lung transplant
脾脏单核细胞在介导肺移植后缺血再灌注损伤中的作用
- 批准号:
10374787 - 财政年份:2019
- 资助金额:
$ 59.15万 - 项目类别:
Pathogenesis of lung injury mediated by lung-restricted antibodies
肺限制性抗体介导的肺损伤的发病机制
- 批准号:
9900583 - 财政年份:2019
- 资助金额:
$ 59.15万 - 项目类别:
Donor nonclassical monocytes initiate lung injury following transplantation
供体非经典单核细胞在移植后引发肺损伤
- 批准号:
10542738 - 财政年份:2019
- 资助金额:
$ 59.15万 - 项目类别:
Donor nonclassical monocytes initiate lung injury following transplantation
供体非经典单核细胞在移植后引发肺损伤
- 批准号:
10093127 - 财政年份:2019
- 资助金额:
$ 59.15万 - 项目类别:
相似海外基金
Establishment of novel osteochondral allografting combined with growth factor- collagen-binding domain fusion technology
新型同种异体骨软骨移植联合生长因子-胶原蛋白结合域融合技术的建立
- 批准号:
26462277 - 财政年份:2014
- 资助金额:
$ 59.15万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Translating PTH Therapy as an Adjuvant for Structural Allografting
将 PTH 疗法转化为结构性同种异体移植的佐剂
- 批准号:
8344380 - 财政年份:2012
- 资助金额:
$ 59.15万 - 项目类别:
Composite Allografting for Promoting Survival of Corneal Transplants
复合同种异体移植促进角膜移植的存活
- 批准号:
7878675 - 财政年份:2009
- 资助金额:
$ 59.15万 - 项目类别:
Composite Allografting for Promoting Survival of Corneal Transplants
复合同种异体移植促进角膜移植的存活
- 批准号:
7677758 - 财政年份:2009
- 资助金额:
$ 59.15万 - 项目类别:
Augmenting Antitumor Immunity after Allografting
增强同种异体移植后的抗肿瘤免疫力
- 批准号:
7466112 - 财政年份:2008
- 资助金额:
$ 59.15万 - 项目类别:
Augmenting Antitumor Immunity after Allografting
增强同种异体移植后的抗肿瘤免疫力
- 批准号:
8010394 - 财政年份:2008
- 资助金额:
$ 59.15万 - 项目类别:
Augmenting Antitumor Immunity after Allografting
增强同种异体移植后的抗肿瘤免疫力
- 批准号:
8208131 - 财政年份:2008
- 资助金额:
$ 59.15万 - 项目类别:
Augmenting Antitumor Immunity after Allografting
增强同种异体移植后的抗肿瘤免疫力
- 批准号:
7575273 - 财政年份:2008
- 资助金额:
$ 59.15万 - 项目类别:
Augmenting Antitumor Immunity after Allografting
增强同种异体移植后的抗肿瘤免疫力
- 批准号:
7765518 - 财政年份:2008
- 资助金额:
$ 59.15万 - 项目类别:














{{item.name}}会员




